GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

CB-13   Click here for help

GtoPdb Ligand ID: 14306

Synonyms: CB13 | CRA-13 | CRA13 | NVP-SAB378
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: This compound behaves as a cannabinoid receptor CB1/CB2 dual agonist [1-2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 0
Rotatable bonds 7
Topological polar surface area 26.3
Molecular weight 368.47
XLogP 5.87
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCCCOC1=C2C=CC=CC2=C(C=C1)C(=O)C3=CC=CC4=C3C=CC=C4
Isomeric SMILES CCCCCOC1=CC=C(C2=CC=CC=C21)C(=O)C3=CC=CC4=CC=CC=C43
InChI InChI=1S/C26H24O2/c1-2-3-8-18-28-25-17-16-24(21-13-6-7-14-22(21)25)26(27)23-15-9-11-19-10-4-5-12-20(19)23/h4-7,9-17H,2-3,8,18H2,1H3
InChI Key RSUMDJRTAFBISX-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Immunopharmacology Comments
CB-13 is orally bioavailable, peripherally active, human CB1/CB2 dual agonist. It is active in inflammatory pain models.